Answers are grounded in this paper and cite their sources.
Poultry processors operate at the intersection of two demanding objectives: reducing microbial contamination and maintaining the economics of high-throughput production. Recent European surveillance shows why neither objective can be treated as solved. In 2024, 24.3% of samples taken during competent-authority monitoring exceeded the Campylobacter process-hygiene threshold of 1,000 CFU/g; the corresponding proportion reported through operators' own checks was 16.4%. Meanwhile, research synthesis reveals inconsistent effects of washing, chilling and newer interventions, with recontamination at defeathering and evisceration offsetting upstream reductions. This study develops a decision framework that prices microbiological performance alongside water, energy, carcass yield, throughput, product loss and regulatory eligibility. A transparent hypothetical plant model shows how apparently attractive interventions can become financially inferior when costs or modest performance losses are included. Finally, it examines reactive mineral transformation of process water, including INTABIOTECH's KNAMAX™/AAI platform, as a testable integration opportunity rather than an independently verified solution. The industrial objective is safer production with demonstrable net value, not another laboratory-only reduction claim.
No takes yet. Share an insight, caveat, or question.
Jose Manuel López (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: